K. O. Akopov
K. O. Akopov has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- E. A. Sokova
Scientific Centre for Expert Evaluation of Medicinal Products
2 shared publications - Raisa Alekseevna Chilova
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University)
2 shared publications - Ruslan Evgenievich Kazakov
Scientific Centre for Expert Evaluation of Medicinal Products
2 shared publications - Elvira V. Zhukova
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
1 shared publication - Guzel Faritovna Proklova
Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication
Latest Publications
- Open Access
- 7 January 2022
- Published by Publishing House OKI in Pharmacogenetics and Pharmacogenomics
- No. 1,p. 9-17
ADRB2 gene polymorphism and preterm labor
This article discusses issues related to the role of polymorphism of the ADRB2 gene encoding β2-adrenergic receptor in preterm labor and tocolysis. Information is provided on scientific studies related to the search for associations of the carriage of alleles and genotypes of ADRB2 with the preterm labor, as well as with the pharmacological response to tocolytic therapy using β2-adrenergic agonists. The history of the discovery of the relationship of ADRB2 gene polymorphisms with preterm labor is presented in chronological order. As scientific facts emerge, researchers are faced with the question: how can ADRB2 gene polymorphisms affect physiological processes? That is, whether they affect by changing the primary structure of the receptor or by changing the level of expression. Depending on the answer to this question, pharmacogenetics are faced with a further task: what to study - individual polymorphisms or haplotypes?
- 7 January 2022
- Published by Publishing House OKI in Pharmacogenetics and Pharmacogenomics
- No. 1,p. 9-17
Open AccessADRB2 gene polymorphism and preterm labor
This article discusses issues related to the role of polymorphism of the ADRB2 gene encoding β2-adrenergic receptor in preterm labor and tocolysis. Information is provided on scientific studies related to the search for associations of the carriage of alleles and genotypes of ADRB2 with the preterm labor, as well as with the pharmacological response to tocolytic therapy using β2-adrenergic agonists. The history of the discovery of the relationship of ADRB2 gene polymorphisms with preterm labor is presented in chronological order. As scientific facts emerge, researchers are faced with the question: how can ADRB2 gene polymorphisms affect physiological processes? That is, whether they affect by changing the primary structure of the receptor or by changing the level of expression. Depending on the answer to this question, pharmacogenetics are faced with a further task: what to study - individual polymorphisms or haplotypes?
- 1 January 2021
- Published by Russian Vrach, Publishing House Ltd. in Врач
- Vol. 32 (9) , 42-44
TOCOLYTIC THERAPY WITH HEXOPRENALINE IN PREGNANT WOMEN AT RISK FOR PREMATURE BIRTH. THE IMPACT OF ADRB2 GENE POLYMORPHISM ON TOCOLYSIS
- 1 January 2021
- Published by Russian Vrach, Publishing House Ltd. in Врач
- Vol. 32 (9) , 42-44
TOCOLYTIC THERAPY WITH HEXOPRENALINE IN PREGNANT WOMEN AT RISK FOR PREMATURE BIRTH. THE IMPACT OF ADRB2 GENE POLYMORPHISM ON TOCOLYSIS